Endocrinology, Vol 130, 3216-3222, Copyright © 1992 by Endocrine Society

ARTICLES

Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes

CV Clevenger, AL Sillman, J Hanley-Hyde and MB Prystowsky
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.

The neuroendocrine hormone PRL acts as a progression factor during interleukin-2 (IL2) stimulated lymphocyte proliferation. Since the sequential expression of cell cycle regulated genes occurs during this process, we examined the contribution of IL2 and PRL to specific RNA accumulation. Stimulation of the cloned T cell line L2 with IL2 and PRL induced the sequential expression of interferon regulatory factor-1, c- myc, proliferating cell nuclear antigen, thymidine kinase, cyclin B, and histone H3. Stimulation of L2 cells with PRL alone, however, induced only the expression of interferon regulatory factor-1. Depletion of PRL, through the use of an anti-PRL antiserum, inhibited IL2 driven proliferation and the expression of cyclin B and histone H3. These results demonstrate that PRL may regulate T cell proliferation by enhancing the expression of some genes necessary for entry into S-phase.

This article has been cited by other articles:

				S. L. Gadd and C. V. Clevenger Ligand-Independent Dimerization of the Human Prolactin Receptor Isoforms: Functional Implications Mol. Endocrinol., November 1, 2006; 20(11): 2734 - 2746. [Abstract] [Full Text] [PDF]

				K Horiguchi, S Yagi, K Ono, Y Nishiura, M Tanaka, M Ishida, and T Harigaya Prolactin gene expression in mouse spleen helper T cells J. Endocrinol., December 1, 2004; 183(3): 639 - 646. [Abstract] [Full Text] [PDF]

				F. V. Lali, J. Crawley, D. A. McCulloch, and B. M. J. Foxwell A Late, Prolonged Activation of the Phosphatidylinositol 3-Kinase Pathway Is Required for T Cell Proliferation J. Immunol., March 15, 2004; 172(6): 3527 - 3534. [Abstract] [Full Text] [PDF]

				O. Gubbay, H. O. D. Critchley, J. M. Bowen, A. King, and H. N. Jabbour Prolactin Induces ERK Phosphorylation in Epithelial and CD56+ Natural Killer Cells of the Human Endometrium J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2329 - 2335. [Abstract] [Full Text] [PDF]

				C. R. Vines and D. A. Weigent Identification of SP3 as a Negative Regulatory Transcription Factor in the Monocyte Expression of Growth Hormone Endocrinology, March 1, 2000; 141(3): 938 - 946. [Abstract] [Full Text] [PDF]

				M. A. RYCYZYN and C. V. CLEVENGER Role of Cyclophilins in Somatolactogenic Action Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 514 - 521. [Abstract] [Full Text] [PDF]

				J. B. Kline, H. Roehrs, and C. V. Clevenger Functional Characterization of the Intermediate Isoform of the Human Prolactin Receptor J. Biol. Chem., December 10, 1999; 274(50): 35461 - 35468. [Abstract] [Full Text] [PDF]

				A. ZOLI, E. M. FERLISI, A. POMPA, A. BARINI, L. ALTOMONTE, L. MIRONE, and M. MAGAROŇ Basal and After-stimuli Test for Prolactinemia in Systemic Lupus Erythematosus Ann. N.Y. Acad. Sci., June 22, 1999; 876(1): 155 - 158. [Full Text] [PDF]

				L. De Petrocellis, D. Melck, A. Palmisano, T. Bisogno, C. Laezza, M. Bifulco, and V. Di Marzo The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation PNAS, July 7, 1998; 95(14): 8375 - 8380. [Abstract] [Full Text] [PDF]

				W.-P. Chang, Y. Ye, and C. V. Clevenger Stoichiometric Structure-Function Analysis of the Prolactin Receptor Signaling Domain by Receptor Chimeras Mol. Cell. Biol., February 1, 1998; 18(2): 896 - 905. [Abstract] [Full Text]

				C. V. Clevenger, K. Thickman, W. Ngo, W.-P. Chang, S. Takayama, and J. C. Reed Role of Bag-1 in the Survival and Proliferation of the Cytokine-Dependent Lymphocyte Lines, Ba/F3 and Nb2 Mol. Endocrinol., May 1, 1997; 11(5): 608 - 618. [Abstract] [Full Text]

				L. Savendahl and L. E. Underwood Decreased Interleukin-2 Production from Cultured Peripheral Blood Mononuclear Cells in Human Acute Starvation J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1177 - 1180. [Abstract] [Full Text] [PDF]

				C. V. Clevenger, W. Ngo, D. L. Sokol, S. M. Luger, and , A. M. Gewirtz Vav Is Necessary for Prolactin-stimulated Proliferation and Is Translocated into the Nucleus of a T-cell Line J. Biol. Chem., June 2, 1995; 270(22): 13246 - 13253. [Abstract] [Full Text] [PDF]

				S. E Walker, S. H Allen, R. W Hoffman, and R. W McMurray Review : Prolactin: a stimulator of disease activity in systemic lupus erythematosus Lupus, February 1, 1995; 4(1): 3 - 9. [PDF]